Brief: Autolus Therapeutics Receives MHRA Certification For Nucleus Commercial Manufacturing Site
12/03/2024 11:14
March 12 (Reuters) - Autolus Therapeutics PLC AUTL.O :
* AUTOLUS THERAPEUTICS RECEIVES MEDICINES AND HEALTHCARE
PRODUCTS
REGULATORY AGENCY (MHRA) CERTIFICATION FOR NUCLEUS COMMERCIAL
MANUFACTURING SITE
Source text for Eikon: ID:nGNX5ypRgl
Further company coverage: AUTL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Autolus Therapeutics
See all newsBrief: Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics
Brief: Autolus Therapeutics Appoints Ryan Richardson To Board Of Directors
Brief: Nice Recommends Aucatzyl As A Treatment Option For Adult Patients With Lymphoblastic Leukemia
Brief: Autolus Therapeutics’ Car T Therapy Aucatzyl® (Obecabtagene Autoleucel) Granted European Marketing Authorization For Adult Patients
Brief: Autolus Therapeutics Announces Inducement Grants